Dignitana AB Publishes May Newsletter

Report this content

Dignitana AB today publishes the May 2019 edition of the company newsletter, attached to this release.

The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. It is posted to the Dignitana website and is available by email subscription here.

Investor Relations

Melissa Bourestom, VP Marketing and Investor Relations, Dignitana  +1 469 518  5031  investorrelations@dignitana.com 

About Dignitana AB (publ)

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com.

Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00  certifiedadviser@penser.se  www.penser.se

Subscribe

Documents & Links